Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Scientific Proposal to Substantiate Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation

NCT05450042 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.

NCT NCT05450042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05450042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Scientific Proposal to Substantiate Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation
Lead sponsor
University Hospital, Essen
Phase
Not applicable
Overall status
Unknown status
Start date
April 6, 2022
Completion date
April 6, 2024
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug eluting balloon, flow-mediated dilation, infrainguinal peripheral arterial disease, peripheral arterial disease